Mechanistic studies suggest that DCIR regulates allergen-induced IgE-mediated mast cell activation through controlling allergen-induced mast cell ROS generation and ox-CaMKII expression, leading to mast cell degranulation and overproduction of inflammatory mediators that trigger skin AD-like inflammation in AD. This evidence concerns the gene CLEC4A and neoplasm.